Futura Medical Plc (FUM) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Animalcare Group Plc

SkinBioTherapeutics Plc

ProBiotix Health Plc

Allergy Therapeutics Plc

Futura Medical Plc

ImmuPharma Plc

Provexis Plc

Cel AI Plc

Chill Brands Group Plc

Gunsynd Plc

Apollon Formularies Plc

Why is Futura Medical Plc ?

Poor Management Efficiency with a low ROE of 2.89%

The company has been able to generate a Return on Equity (avg) of 2.89% signifying low profitability per unit of shareholders funds

With a fall in Net Sales of -85.54%, the company declared Very Negative results in Jun 25

The company has declared negative results in Jan 70 after 2 consecutive negative quarters
RAW MATERIAL COST(Y) Grown by 52.03% (YoY)
CASH AND EQV(HY) Lowest at GBP 3.69 MM
NET SALES(Q) Lowest at GBP 1 MM

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -88.57%, its profits have fallen by -67.7%

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -88.57% returns in the last 1 year, the stock has also underperformed FTSE 100 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Futura Medical Plc for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Futura Medical Plc

-100.0%

-0.83

117.03%

FTSE 100

13.98%

1.15

13.60%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

54.84%

EBIT Growth (5y)

2.23%

EBIT to Interest (avg)

-5.70

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.74

Sales to Capital Employed (avg)

1.20

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.00%

ROCE (avg)

9.43%

ROE (avg)

2.89%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

2.37

EV to EBIT

-0.55

EV to EBITDA

-0.56

EV to Capital Employed

-3.52

EV to Sales

0.44

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-206.60%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

OPERATING CASH FLOW(Y)

Highest at GBP -1.27 MM

-19What is not working for the Company

RAW MATERIAL COST(Y)

Grown by 52.03% (YoY

CASH AND EQV(HY)

Lowest at GBP 3.69 MM

NET SALES(Q)

Lowest at GBP 1 MM

OPERATING PROFIT(Q)

Lowest at GBP -6.66 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -665.45 %

PRE-TAX PROFIT(Q)

Lowest at GBP -6.69 MM

NET PROFIT(Q)

Lowest at GBP -6.59 MM

EPS(Q)

Lowest at GBP -0.02

Here's what is working for Futura Medical Plc

Operating Cash Flow

Highest at GBP -1.27 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (GBP MM)

Here's what is not working for Futura Medical Plc

Net Sales

At GBP 1 MM has Fallen at -85.7%

Year on Year (YoY)

MOJO Watch

Near term sales trend is extremely negative

Net Sales (GBP MM)

Pre-Tax Profit

At GBP -6.69 MM has Fallen at -871.48%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (GBP MM)

Net Profit

At GBP -6.59 MM has Fallen at -757.52%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (GBP MM)

Net Sales

Lowest at GBP 1 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (GBP MM)

Operating Profit

Lowest at GBP -6.66 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (GBP MM)

Operating Profit Margin

Lowest at -665.45 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at GBP -6.69 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (GBP MM)

Net Profit

Lowest at GBP -6.59 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (GBP MM)

EPS

Lowest at GBP -0.02

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (GBP)

Cash and Eqv

Lowest at GBP 3.69 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Raw Material Cost

Grown by 52.03% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales